Business & Finance

Novo Nordisk rebrands as Novo to accelerate weight-loss market strategy

The Danish drugmaker is shifting its corporate brand as it faces increasing competition from Eli Lilly.

Updated Sep 14, 2026 · 10:48 UTC2 reports

The short version

Novo Nordisk announced it is rebranding as Novo and updating its corporate culture to improve focus and speed.[CNBC · STAT]
The firm faces fierce competition from Eli Lilly, which led the obesity drug market with a 60.9% share in the second quarter compared to Novo's 38.8%.[CNBC]
Novo Nordisk will remain the legal company name, with further strategic details scheduled for a Sept. 21 presentation.[CNBC]

Novo Nordisk announced it is adopting "Novo" as its brand name and updating its corporate culture.[CNBC · STAT]
Novo Nordisk will remain the official legal name of the company.[CNBC]
According to IQVIA data cited in a Lilly earnings presentation, Novo held a 38.8% share of the obesity market in the second quarter compared to Eli Lilly's 60.9%.[CNBC]
The oral version of Wegovy exceeded 3 million prescriptions by June.[CNBC]
Novo plans to outline additional business strategy changes at its Capital Markets Day on Sept. 21.[CNBC]

The precise extent of stock decline varies by reporting period, with CNBC reporting a drop of about 15% this year and STAT reporting a drop of nearly 20% over the past year.[CNBC · STAT]

Outlet counts describe coverage, not independent confirmation. Reports may share a wire service or original source.